Licensing Opportunities

Two engines, licensed independently or together, into the industries where a plant-derived compound has to hold both its value and its identity.

The licensing thesis

HyGyHya develops enabling technology for other organizations rather than a consumer product brand. Partners license the engine, integrate it into their own pipeline, and keep their own program.

Platform snapshot as of September 2026

2
Licensable engines
27
Engine One verticals
30
Engine Two verticals
5
Science disciplines

The thesis in four parts.

A scientist purging oxygen from pharmaceutical sample vials before sealing

Core bottleneck

Addresses a fundamental constraint limiting scalability across plant-derived and complex therapeutics.

A technical transfer team reviewing pharmaceutical process integration beside a production facility

Platform exposure

Multi-asset applicability across compounds, programs and industries, not a single-product commercialization.

Sealed pharmaceutical product being verified against its lifecycle record

Dual architecture

Two engines that license independently. Stability and delivery in one, integrity and provenance in the other.

Quality professionals reviewing a batch record and an in-process sample

Regulatory alignment

Aligned with increasing emphasis on reproducibility, traceability and documented integrity.

What is available to license.

One engine holds the compound stable. The other proves what the material is. Either licenses on its own.

Engine One

Botanical Stability & Targeted Delivery

Proprietary stabilization of isolated plant-derived compounds, preserving chemical integrity through handling, storage and formulation.

Chemical integrity
Holds the compound within defined specifications against oxidation, light, temperature and enzymatic degradation.
Research comparability
Reduces the input variability that complicates comparison across lots, sites and time.
Commercial reliability
Cuts the retesting, handling controls and uncertain usable life that add development work.
Targeted delivery
Delivery remains part of the architecture. No clinical absorption or pharmacokinetic claim is made from stability alone.
Review the science

Engine Two

Botanical Integrity, Provenance & Traceability

Material-based identity verification and documented lifecycle continuity: source, handling and comparability over time.

Material signature
Captures intrinsic chemical characteristics of the compound itself through a non-destructive sensing approach.
Reference and records
Compares against qualified reference data and links documented source and handling events to the result.
Verifiable continuity
Supports identity, comparability, anomaly review and an auditable lifecycle record across custody changes.
Anti-counterfeit and enforcement
Verifies the material rather than the label, which is what counterfeiting, diversion and tax enforcement turn on.
Review the science

Industries we license into.

Either engine licenses independently into its own set of markets. These are the verticals in scope today.

Engine One

Botanical Stability & Targeted Delivery

27 verticals

  • Pharmaceuticals
  • Botanical drugs
  • Nutraceuticals
  • Dietary supplements
  • Functional foods
  • Functional beverages
  • Cannabis and hemp products
  • Over-the-counter therapeutics
  • Prescription botanical therapeutics
  • Veterinary therapeutics
  • Animal health and nutrition
  • Cosmetics
  • Cosmeceuticals
  • Personal care
  • Fragrances and essential oils
  • Traditional and herbal medicines
  • Mycological and mushroom-derived compounds
  • Agricultural biologicals
  • Plant-derived pesticides and biocontrol
  • Food ingredients and natural preservatives
  • Flavor and aroma compounds
  • Research reagents and reference materials
  • Clinical research formulations
  • Botanical extraction and processing
  • Industrial botanical chemicals
  • Biofuels and plant-derived feedstocks
  • Biomaterials and plant-derived industrial products

Engine Two

Botanical Integrity, Provenance & Traceability

30 verticals

  • Pharmaceutical supply chains
  • Botanical-drug supply chains
  • Cannabis and hemp
  • Nutraceuticals and supplements
  • Food and beverage
  • Agriculture
  • Seed genetics and certified seed
  • Crop authentication
  • Ingredient authentication
  • Cosmetics and personal care
  • Essential oils
  • Herbal medicine
  • Mycological products
  • Veterinary products
  • Agricultural biologicals
  • Biofuel feedstocks
  • Biomass commodities
  • Textiles and natural fibers
  • Hempcrete and building materials
  • Lumber and plant-derived construction materials
  • Government-regulated supply chains
  • Customs and import-export verification
  • Laboratory and research-chain integrity
  • Clinical-trial material authentication
  • Anti-counterfeiting
  • Chain-of-custody systems
  • ESG and sustainability verification
  • Geographic-origin verification
  • Cultivar, lineage and genetics verification
  • Commodity trading and certification

How a license is reached

License the application. Retain controlled supply.

Initial target partners are research-material suppliers, formulation developers and ingredient manufacturers with a defined stability or integrity problem. The decision turns on retention, degradants, reproducibility, compatibility and total cost.

Operators monitor a pharmaceutical packaging line beside staged cold-chain shipping containers

The commercial sequence

A proposed sequence. No signed partner, price or adoption is represented here.

01

Paid evaluation

We test your material against agreed performance and compatibility criteria. This is the first commercial gate, not an assumed multi-year license.

Evaluation work underway in a controlled pharmaceutical environment

02

Development

We build reproducibility, quality documentation and an integration plan against your process.

Partner review meeting over pharmaceutical technical documentation

03

License and supply

Field-limited rights with controlled enabling-material supply and negotiated recurring economics.

Verification of finished product on a pharmaceutical line

04

Integration and scale

Deployment across additional compounds, programs and geographies as each prior stage holds.

Cold-chain shipments staged for multi-market pharmaceutical distribution

Defensibility

Protect the enabling material, then prove the partner benefit against their existing formulation, packaging and storage controls.

Proprietary know-how

Formulation and manufacturing knowledge protected through restricted access and appropriate agreements.

Controlled core supply

The enabling material and its release specifications stay central to partner integration.

Data and IP strategy

Traceable methods and supporting evidence developed alongside a counsel-led patent and trade-secret strategy.

Licensing questions

Two engines. Engine One is Botanical Stability and Targeted Delivery, the proprietary stabilization of isolated plant-derived compounds. Engine Two is Botanical Integrity, Provenance and Traceability, which verifies material identity and documents lifecycle continuity. Each licenses on its own.

Yes. Both are independently deployable and are licensed that way. They are complementary rather than dependent, so a partner who needs only stability, or only provenance, can take one and integrate it alone.

Engine One licenses into 27 verticals spanning pharmaceuticals, botanical drugs, nutraceuticals, food and beverage, cosmetics, veterinary, agricultural and industrial botanical applications. Engine Two licenses into 30, including regulated supply chains, customs verification, anti-counterfeiting, seed genetics, textiles, biomass and commodity certification. Both lists appear on this page in full.

With a scoped, paid evaluation of your material against agreed performance and compatibility criteria. Development and then a field-limited license with controlled supply follow from what that evaluation shows.

HyGyHya develops enabling technology for other organizations rather than a consumer product brand. Revenue comes from field-limited licensing with controlled enabling-material supply and negotiated recurring economics.

Use the Contact page or email info@hygyhya.com. Technical materials and validation records are available under appropriate confidentiality agreements.